Tonix Pharmaceuticals

#Antibody-based therapeutics #Interview #Lyme Disease #Monoclonal antibodies #Tonix Pharmaceuticals

Is monoclonal antibody prophylaxis the answer to the growing threat of Lyme?

Diana Turner catches up with Seth Lederman, Co-Founder, CEO and Chairman of Tonix Pharmaceuticals, about the company’s new preventative monoclonal antibody therapy for Lyme disease.  DT: For anyone who hasn’t come across the disease before, what is Lyme disease and how is it contracted? SL: Lyme disease is a tick‑borne… Read More

#Exclusive Content

Woman with painful shoulder
#Chronic pain #Fast Track designation #FDA #Fibromyalgia #Tonix Pharmaceuticals

FDA fast-tracks first new fibromyalgia drug in 15 years

The US Food and Drug Administration (FDA) has granted Fast Track designation to Tonix Pharmaceuticals’ Tonmya (cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia. Tonmya is a non-opioid, centrally-acting analgesic drug under development for treating fibromyalgia, which is a common chronic pain condition affecting mostly women. The company says… Read More

#News #Regulatory